SHINE plans new isotope production facility in the Netherlands

May 24, 2021, 7:00AMNuclear News
A rendering of the SHINE medical isotope production facility planned for construction in Veendam, the Netherlands. (Image: Shine)

SHINE Medical Technologies plans to locate its European medical isotope production facility in the Netherlands after a yearlong search and a review of more than 50 proposals from sites across Europe. The company announced on May 20 that construction at the site should begin in 2023 with commercial production starting in late 2025.

To continue reading, log in or create a free account!

Related Articles

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Mirion announces appointments

February 12, 2026, 3:46PMNuclear News

Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The...

A focus on clean energy transition

October 14, 2025, 9:30AMANS Nuclear Cafe

Michigan-based consulting firm Ducker Carlisle has released a report that outlines projected developments and opportunities as well as potential problems in the global shift to cleaner power....